$ACHN Company News Achillion Pharma's stock ju
Post# of 145246
Posted On: 12/26/2014 11:40:16 AM
$ACHN Company News
Achillion Pharma's stock jumps 60% premarket after positive drug trial results 7:30 a.m. Dec. 22, 2014 - Tomi Kilgore
4 stocks to watch 3:41 p.m. Dec. 3, 2014 - The Trading Deck
6 stocks to watch 1:35 p.m. Oct. 29, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
6 stocks to watch 2:36 p.m. Oct. 9, 2014 - The Trading Deck
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 12:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 10:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 3:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 8:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 9:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
February 2015 Options Now Available For Achillion Pharmaceuticals 12:30 p.m. Dec. 24, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Dec. 24, 2014 - Zacks.com
Morning Market Movers 8:42 a.m. Dec. 24, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Dec. 24, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog 5:00 p.m. Dec. 23, 2014 - Zacks.com
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Mid-Day Losers From December 23: Achillion Pharmaceuticals, Doral Financial, Keurig Green Mountain And More 12:44 p.m. Dec. 23, 2014 - benzinga.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
Worst Performing Industries For December 23, 2014 10:25 a.m. Dec. 23, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations 9:40 a.m. Dec. 23, 2014 - benzinga.com
Morning Market Losers 9:03 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Rises: Stock Adds 9% in Session - Tale of the Tape 8:44 a.m. Dec. 23, 2014 - Zacks.com
Analysts' Actions: Achillion, Avon, Kimberly-Clark, Salesforce.com 8:24 a.m. Dec. 23, 2014 - TheStreet.com
Tuesday's #PreMarket Movers: NQ Mobile, Cytokinetics, Walgreen And More 8:23 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 8:21 a.m. Dec. 23, 2014 - Zacks.com
Benzinga's Top Downgrades 8:00 a.m. Dec. 23, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Baker Hughes, CryoLife, Halliburton, Nabors, Red Hat, Sonus and More 8:00 a.m. Dec. 23, 2014 - 247WallSt.com
Baird Downgrades Achillion Pharmaceuticals To Neutral 6:54 a.m. Dec. 23, 2014 - benzinga.com
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
Traders Look to Upside: Research Reports on Achillion, Civitas, Twitter, Petrobras, and Zynga 8:50 a.m. Dec. 23, 2014 - PR Newswire - PRF
Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics 9:10 a.m. Dec. 22, 2014 - PR Newswire - PRF
Achillion Shows Potential for "Best-in-Disease" HCV Regimen - 100% SVR4 Following a Dual 6-Week ACH-3102-Based Regimen and Separately a 4.8 Log10 Reduction With ACH-3422 6:30 a.m. Dec. 22, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Linn Energy, Sears Holdings, Baidu and Qualcomm Released By InvestorsObserver 9:31 a.m. Dec. 1, 2014 - PR Newswire - PRF
Achillion to Present at Two Upcoming Investor Conferences 6:05 a.m. Nov. 25, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. Nov. 11, 2014 - PR Newswire - PRF
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD) 9:02 a.m. Nov. 8, 2014 - GlobeNewswire
Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform at the 56th Annual Meeting of the American Society of Hematology 9:02 a.m. Nov. 6, 2014 - GlobeNewswire
Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Achillion Reports Third Quarter and Nine Month 2014 Financial Results 6:31 a.m. Nov. 4, 2014 - GlobeNewswire
Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Oct. 27, 2014 - PR Newswire - PRF
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:24 a.m. Oct. 8, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 8:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 8:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 7:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 8:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 7:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
Achillion Pharma's stock jumps 60% premarket after positive drug trial results 7:30 a.m. Dec. 22, 2014 - Tomi Kilgore
4 stocks to watch 3:41 p.m. Dec. 3, 2014 - The Trading Deck
6 stocks to watch 1:35 p.m. Oct. 29, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
6 stocks to watch 2:36 p.m. Oct. 9, 2014 - The Trading Deck
10 Nasdaq stocks with returns of at least 240% in 2014 4:38 p.m. Sept. 11, 2014 - Philip van Doorn
5 stocks to watch 12:38 p.m. Sept. 3, 2014 - The Trading Deck
Six stocks to watch 12:47 p.m. Aug. 27, 2014 - The Trading Deck
S&P 500 reaches firmer technical ground 10:30 a.m. Aug. 18, 2014 - Michael Ashbaugh
Stocks trim Ukraine-inspired fall, post weekly gain 3:08 p.m. Aug. 15, 2014 - Anora Mahmudova
In focus: New highs premature? 8:03 p.m. June 18, 2014 - Lawrence G. McMillan
Achillion shares up; FDA lifts hold on hepatitis C drug 9:25 a.m. June 10, 2014 - Anna Prior
U.S. stock futures sink on shutdown fears 7:38 a.m. Sept. 30, 2013 - Barbara Kollmeyer
Zynga shares rise, Achillion drops after hours 4:51 p.m. July 1, 2013 - Wallace Witkowski
FDA puts Achillion Hep C drug on clinical hold 4:16 p.m. July 1, 2013 - MarketWatch.com
Five stocks making moves 2:12 p.m. Feb. 14, 2013 - The Trading Deck
Thursday’s top gaining & declining stocks 4:02 p.m. Sept. 27, 2012 - Greg Morcroft
Achillion sees progress in hepatitis C study 8:04 a.m. Sept. 27, 2012 - MarketWatch.com
Vertex to advance testing of oral HCV drug regimen 9:34 a.m. Sept. 25, 2012 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:37 p.m. Sept. 19, 2012 - MarketWatch
February 2015 Options Now Available For Achillion Pharmaceuticals 12:30 p.m. Dec. 24, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Dec. 24, 2014 - Zacks.com
Morning Market Movers 8:42 a.m. Dec. 24, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:09 a.m. Dec. 24, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
Achillion Gains on Positive Results from its HCV Candidates - Analyst Blog 5:00 p.m. Dec. 23, 2014 - Zacks.com
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Mid-Day Losers From December 23: Achillion Pharmaceuticals, Doral Financial, Keurig Green Mountain And More 12:44 p.m. Dec. 23, 2014 - benzinga.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
Worst Performing Industries For December 23, 2014 10:25 a.m. Dec. 23, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations 9:40 a.m. Dec. 23, 2014 - benzinga.com
Morning Market Losers 9:03 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Rises: Stock Adds 9% in Session - Tale of the Tape 8:44 a.m. Dec. 23, 2014 - Zacks.com
Analysts' Actions: Achillion, Avon, Kimberly-Clark, Salesforce.com 8:24 a.m. Dec. 23, 2014 - TheStreet.com
Tuesday's #PreMarket Movers: NQ Mobile, Cytokinetics, Walgreen And More 8:23 a.m. Dec. 23, 2014 - benzinga.com
Achillion Pharmaceuticals (ACHN) Shares March Higher, Can It Continue? - Tale of the Tape 8:21 a.m. Dec. 23, 2014 - Zacks.com
Benzinga's Top Downgrades 8:00 a.m. Dec. 23, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Baker Hughes, CryoLife, Halliburton, Nabors, Red Hat, Sonus and More 8:00 a.m. Dec. 23, 2014 - 247WallSt.com
Baird Downgrades Achillion Pharmaceuticals To Neutral 6:54 a.m. Dec. 23, 2014 - benzinga.com
Critical Alerts For Achillion Pharmaceuticals, AT&T, Peabody Energy, Gilead Sciences and Facebook Released By InvestorsObserver 9:31 a.m. Dec. 23, 2014 - PR Newswire - PRF
Traders Look to Upside: Research Reports on Achillion, Civitas, Twitter, Petrobras, and Zynga 8:50 a.m. Dec. 23, 2014 - PR Newswire - PRF
Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics 9:10 a.m. Dec. 22, 2014 - PR Newswire - PRF
Achillion Shows Potential for "Best-in-Disease" HCV Regimen - 100% SVR4 Following a Dual 6-Week ACH-3102-Based Regimen and Separately a 4.8 Log10 Reduction With ACH-3422 6:30 a.m. Dec. 22, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, Linn Energy, Sears Holdings, Baidu and Qualcomm Released By InvestorsObserver 9:31 a.m. Dec. 1, 2014 - PR Newswire - PRF
Achillion to Present at Two Upcoming Investor Conferences 6:05 a.m. Nov. 25, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver 9:31 a.m. Nov. 11, 2014 - PR Newswire - PRF
Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD) 9:02 a.m. Nov. 8, 2014 - GlobeNewswire
Achillion Announces Upcoming Poster Presentations Discussing Novel Oral Complement Factor D Inhibitor Platform at the 56th Annual Meeting of the American Society of Hematology 9:02 a.m. Nov. 6, 2014 - GlobeNewswire
Biotech Equities Coverage - Achillion Pharma, Sarepta Therapeutics, Alnylam Pharma, Incyte, and Cytori Therapeutics 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Achillion Reports Third Quarter and Nine Month 2014 Financial Results 6:31 a.m. Nov. 4, 2014 - GlobeNewswire
Critical Alerts For NetSuite, CVS Caremark, Netflix, VeriFone Systems and Achillion Pharmaceuticals Released By InvestorsObserver 8:31 a.m. Oct. 27, 2014 - PR Newswire - PRF
Achillion to Present Updated Clinical HCV Data on ACH-3102 and Preclinical Profile of ACH-3422 at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 9:24 a.m. Oct. 8, 2014 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Dreamworks Animation, SunEdison, El Pollo Loco and Whole Foods Market Released By InvestorsObserver 8:31 a.m. Sept. 30, 2014 - PR Newswire - PRF
Biotech Stocks Technical Data - Medivation, Galectin Therapeutics, Ironwood Pharma, Achillion Pharma, and PDL BioPharma 8:05 a.m. Sept. 16, 2014 - PR Newswire - PRF
Critical Alerts For Achillion Pharmaceuticals, LightInTheBox, VoxelJet, Whole Foods Market and Disney Released By InvestorsObserver 8:31 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Updates, Operational Milestones, Product Upgrades, and Energy Saving Programs - Research Reports on Achillion, DE, Honeywell, Lockheed Martin and L-3 Communications 7:35 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 8:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Reveal Insider Trading for Facebook, Plug Power, Achillion Pharmaceuticals, Apple, Twitter, and Intel 7:55 a.m. Sept. 2, 2014 - PR Newswire - PRF
(0)
(0)